An interventional study of stress-coping week and additional two days follow-up weekend in Affective Disorders, Psychological Stress and Inflammation, sponsored by Medical University of Vienna. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-09-16.
Sponsored by Medical University of Vienna · Not applicable, Interventional, and Prevention
This study intents to determine who will benefit from an intensive brief stress coping intervention week (ISCIW) as secondary prevention for real world affective disorder patients.
Affective disorders are associated with a substantial personal and socio-economic burden. This study evaluates an intensive brief stress-coping intervention week (ISCIW) as feasible follow-up treatment for real world patients who suffer from this highly prevalent and chronic stress-related disorders. Stress-associated blood (Interleukin-6, Homocystein, Myeloperoxidase), saliva cortisol and psychosocial screening parameters will be analyzed to determine who will benefit from the ISCIW. All patients were identified in a preventive medical screening before pre-treatment for at least three month as outpatient and the following inclusion to the follow-up ISCIW-trial at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria. For the three planed groups and interventions see interventions and arms.
3,439 studies on the registry are indexed under Inflammation; 629 are open to participants now.
This study's enrollment of 43 is below the median of 50 across 2,437 interventional studies indexed under Inflammation.
Browse Inflammation studies →Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
control group / waiting list one week stress-coping intervention planned after end of study (EOS) without one week stress-coping intervention AND without an additional two days follow-up care
active comparator with one week stress-coping intervention BUT without an additional two days follow-up weekend
Behavioral: stress-coping week
active comparator with one week stress-coping intervention AND with an additional two days follow-up weekend
Behavioral: stress-coping week · Behavioral: additional two days follow-up weekend
The multidisciplinary team will offer Mindfulness-Based Stress Reduction (MBSR), group psychotherapy (resilience, Cognitive Behavioral Analysis System of Psychotherapy CBASP, psychodynamic therapy), relaxation training, nutrition course, stress-coping and physical training in a group setting.
A two-days follow-up which recapitulates previous treatment elements.
Change of saliva cortisol
Time frame: Change from baseline saliva sample at week 1 to end of study visit at week 38
Change of myeloperoxidase
Time frame: Change from baseline at week 1 to end of study visit at week 38
Change of interleukin-6
Time frame: Change from baseline at week 1 to end of study visit at week 38
Change of homocystein
Time frame: Change from baseline at week 1 to end of study visit at week 38
Change of psychometric stress-index (Questionnaire)
Time frame: Change from baseline at week 1 to end of study visit at week 38
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna